These results confirmed conclusions of previous studies reporting similar effects of SEC62 gene silencing on lung cancer, prostate cancer, fibrosarcoma, glioblastoma and thyroid cancer cell lines [15, 23], as well as effects of SEC62 overexpression on human embryonic kidney cells [24]. This evidence concerns the gene SEC62 and Familial prostate cancer.